Skip to main content
2026 CRT Conference Main banner

CRT 2026

Innovation and Technology

Session:: HBD West 2026 | Positioning US-Japan Synergies for the Future [Non-CME]

Panel Discussion | What Else is Needed to Demonstrate the Feasibility of Global Registries?

Sunday, March 8, 2026
10:35 AM - 11:20 AM EST

    Moderator(s)

  • David Erlinge, MD, PhD

    Professor, Consultant Interventional Cardiology
    Lund University
    Lund, Sweden

    Disclosure(s): chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)

  • Misti Malone, PhD

    Deputy Director, Office of Cardiovascular Devices
    FDA
    Silver Spring, Maryland, United States

    Disclosure information not submitted.

    • Panel Discussant(s)

  • SI

    Shin Iwamoto, PhD

    Principal Reviewer
    Pharmaceuticals and medical devices agency
    Chiyoda-ku, Tokyo, Japan

    Disclosure information not submitted.

  • Mitchell Krucoff, MD, FACC, FAHA, FSCAI

    Professor Medicine/Cardiology
    Duke University Medical Center/Duke Clinical Research Institute
    Durham, North Carolina, United States

    Disclosure information not submitted.

  • Mauro Moscucci, MD, MBA, MPH

    Medical Officer
    Food and Drug Administration, Center for Devices and Radiological Health, Maryland, United States

    Disclosure(s): No financial relationships to disclose

Disclosure(s):
David Erlinge, MD, PhD: chiesi, bracco: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); kaminari, medical: Consulting Fees (e.g., advisory boards) (Ongoing)
Mauro Moscucci, MD, MBA, MPH: No financial relationships to disclose